Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




New WHO Guidelines to Revolutionize AI in Healthcare

By HospiMedica International staff writers
Posted on 24 Oct 2023

As healthcare data becomes increasingly abundant and analytical methods like machine learning, logic-based systems, and statistical techniques advance, artificial intelligence (AI) has the potential to reshape the healthcare landscape. More...

However, the quick deployment of AI, including large language models, sometimes occurs without fully understanding their performance implications, which could be either advantageous or detrimental to end-users like healthcare providers and patients. Given that AI systems can handle sensitive personal data, it is crucial to have strong legal and regulatory measures in place to protect privacy, security, and integrity.

The World Health Organization (WHO, Geneva, Switzerland) has released a new publication that outlines critical regulatory factors concerning the use of AI in healthcare. The report underscores the need for verifying the safety and efficacy of AI systems, rapidly making beneficial systems accessible to those in need, and encouraging discussions among various stakeholders like developers, regulators, healthcare staff, and patients. WHO acknowledges that AI can significantly enhance healthcare by bolstering clinical trials, enhancing medical diagnostics, treatments, self-care, and individualized care, and supporting healthcare professionals in various ways. For instance, AI can be especially useful in environments where there's a shortage of medical specialists, helping with tasks like interpreting retinal scans and radiological images. The document specifies six key regulatory areas for healthcare AI, which include transparency and documentation, risk management, validating data and clarity on the intended use of AI, data quality, privacy and data protection, and collaboration.

AI systems are complex and influenced not just by the algorithms they are built on but also the data they are trained with, often sourced from clinical environments and user interactions. Effective regulation can manage the risks associated with AI systems amplifying biases present in the training data. For example, AI models might struggle to capture the diversity of different populations, resulting in biases or even inaccuracies. To minimize such risks, regulations can ensure that attributes like gender, race, and ethnicity in the training data are transparently reported and that data sets are deliberately made to be representative. The WHO's new publication aims to provide a framework of fundamental principles that national or regional governments and regulatory bodies can adopt or adapt for AI guidance in healthcare.

Related Links:
WHO


Platinum Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Isolation Stretcher
IS 736
Xenon Light Source
CLV-S400
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.